The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature. 

Meanwhile, docs have helped defeat the controversial policy's implementation in Indiana with the passage of Senate Bill 189. 

The downgrade comes amid concerns the radiology provider may have overpaid in its $270 million bid to buy Paris-based AI firm Gleamer.  

Stryker, a Michigan-based company that manufactures surgical implants, confirmed it was experiencing a global network outage. Employee devices reportedly displayed the logo of a pro-Iran cybercrime cell.

That's according to findings from the largest NHS study on the use of AI in breast cancer screening settings to date. 

The U.S. Department of Justice said the insurer upcoded patient diagnoses to boost risk-adjusted payments it received from the Centers for Medicare & Medicaid Services. The company did not admit to wrongdoing, despite agreeing to the payout. 

However, the regular supply of these imaging radiotracers may not be back online for another few months.

BrainBot's development represents a significant step forward for image-guided interventional procedures, as fully robotic neurosurgical devices are not designed to be MRI-compatible.  

The newly cleared device was built to provide support, trackability and stability during the treatment of time-sensitive stroke patients. 

When working-age adults develop cardiovascular disease, it often ends up eating up a significant amount of their income. Are insurance companies doing enough to help these patients?